# Bryon McGregor

Type: Person

Source: GetYourBrief — https://getyourbrief.com/entity/bryon-mcgregor
Canonical HTML page: https://getyourbrief.com/entity/bryon-mcgregor

## Recent coverage (3 stories, network-wide)

### MEC’s Data Center Revenue Rockets 173% as AI Buildout Fuels Demand
2026-08-08 22:30:49 · Sector: proptech · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Mayville Engineering’s Q2 results reveal a staggering 173% organic growth in data center and critical power revenue, underscoring the property-tech sector's long-term structural tailwind from artificial intelligence. With a pipeline exceeding $125 million, MEC is a bellwether for the construction boom in digital infrastructure.
Full story: https://getproptechbrief.com/story/mayville-engineering-data-center-surge-q2-2026

### Alto Ingredients' Crush Margin Triples, Drives 4th Profitable Quarter
2026-08-08 22:30:36 · Sector: climate · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Biofuel producer Alto Ingredients posted its fourth straight profitable quarter as crush margins expanded to $0.33 per gallon from $0.11 a year ago and 45Z tax credits kicked in. The results demonstrate how federal low-carbon fuel policy is strengthening the ethanol business case.
Full story: https://getclimatebrief.com/story/alto-ingredients-profitability-renewable-fuel-credits-q2-2026

### Urogen's ZUSDURI Revenue Soars 73% to $50.4M, Expanding Prescriber Base
2026-08-08 22:30:23 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Urogen Pharma’s bladder cancer therapy ZUSDURI generated $50.4M in Q2 net product revenue, a 73% sequential jump, as the company activated 1,444 accounts and doubled repeat prescribers. The strong commercial launch highlights robust demand in biotech’s niche oncology space.
Full story: https://getbiobrief.com/story/urogen-pharma-zusduri-revenue-surge-q2-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.